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Abstract 
 
 
With the inevitable adoption of information technology into all areas of human pursuit, 
the potential benefits for health care should not be overlooked.  In Australia, details of 
most health care encounters are currently recorded for administrative purposes.  This 
results in an impressive electronic data-bank that could provide a national resource for 
health service evaluation. 
 
Evaluation of health services has become increasingly important to provide indicators of 
the benefits, risks and cost-effectiveness of treatments.  However, if administrative data 
are to be used for this purpose, several questions must first be addressed:  Are the 
current data collections accessible?  What outcome measures can be derived from these 
data?  Can privacy issues be managed?  Could the quality of the data be improved?  Is 
the existing infrastructure adequate to supply data for evaluation purposes?  Could the 
existing system provide a basis for the development of an integrated health information 
system? 
 
The aims of the project were: 
• To examine the potential for using administrative data to generate outcome 
measures and surveillance indicators. 
• To investigate the logistics of gaining access to these data for the purpose of 
research.  This to be achieved within the current ethical, political and financial 
framework. 
• To compare the Australian health-service data system with the current international 
state-of-the-art. 
• To develop suggestions for expansion of the present system as part of an integrated 
health record and information system.  This system to manage patient records and 
provide data for quality management, treatment surveillance and cost-effectiveness 
evaluation as a routine activity. 
 
The thesis is presented in two parts.  In the first part, a historical cohort study is 
described that involved patients with implantable medical devices. The potential to 
evaluate outcomes was investigated using all national health-service information 
currently available in electronic form.  Record linkage techniques were used to combine 
Abstract 
 vi
and augment the existing data collections.  Australia’s national health databases are to 
varying degrees, amenable to such linkage and cover doctor visits, pharmaceuticals, 
hospital admissions and deaths.  The study focused on medical devices as an illustrative 
case but the results are applicable to the routine assessment of all medical and surgical 
interventions. 
 
For the Australian ‘Medical Devices study’, the records of 5,316 patients who had 
medical device implants in 1993-94 were selected from the archives of a major private 
health insurer.  Five groups of medical implants were studied: heart valves, pacemakers, 
hips, vascular grafts and intra-optic lenses. Outcomes for these patients, including death, 
re-operation and health service utilisation, were compared and analysed.  
 
A comparison study was performed using data from the Manitoba Health database in 
Winnipeg, Canada. Manitoba provides a very similar demographic group to that found 
in Australia and is an example of a prototype integrated-health-information system.  
One of the principal advantages for research is that personally identified data about 
medical and hospital services are collected for all patients.  Selection bias is eliminated 
because individual consent is not required for this type of research and all selected 
patients could be included in the study.  
 
The two studies revealed many barriers to the use of administrative data for health 
outcomes research.  Service event data for the Australian cohort could be collected but 
only after long delays and hospital morbidity data were not available for the entire 
cohort.  In contrast to the situation in Australia, the Manitoba data were both accessible 
and complete, but were lacking in detail in some areas. 
 
Analysis of the collected data demonstrated that without the addition of clinical data 
only general indications of trends could be deduced.  However, with minimal 
supplementary clinical data, it was possible to examine differences in performance 
between brands of medical devices thus indicating one of the uses for this type of data 
collection. 
 
In the second part of the thesis, conclusions are presented about the potential uses and 
limitations of the existing system and its use as a basis for the development of a national 
Abstract 
 vii
Integrated Health Record and Information System (IHRIS).  The need for the 
establishment of a systemic quality management system for health care is discussed. 
 
The study shows that linked administrative data can provide information about health 
outcomes which is not readily available from other sources.  If expanded and integrated, 
the system that is currently used to collect and manage administrative data, could 
provide the basis for a national health information system.  This system would provide 
many benefits for health care.  Benefits would include the monitoring, surveillance and 
cost-effectiveness analysis of new and existing treatments involving medical devices, 
drugs and surgical procedures.  An integrated health information system could thus 
provide for both clinical and administrative needs, while in addition providing data for 
research. 
 
Unfortunately,  in Australia, the use of administrative data for this purpose is not 
currently feasible.  The principal barrier is the existence of a culture within the 
Australian health care system which is not supportive of research and is deficient in 
quality and safety measures.  
 
Recent initiatives by both the Commonwealth and state governments have supported the 
introduction of measures to improve quality and safety in health care.  It is argued here 
that an Integrated Health Record and Information System (IHRIS) would provide an 
essential component of any such scheme.  The results of this study have important 
policy implications for health care management in both the administrative and clinical 
domains. 
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The desire for safety stands against every great and noble enterprise
Cornelius Tactitus,  AD 56-120 
 
 
 
Anyone who has never made a mistake has never tried anything 
new.  Albert Einstein. 
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Preface 
 
This research project was conceived during my time working within the Commonwealth 
Department of Health in the area of medical device regulation.  As medical advisor, I 
witnessed the limitations of pre-market evaluation of new products, the inadequate 
system of ‘problem’ reporting and the challenge of implementing safety alerts and 
product recalls for faulty devices. When problems with a heart-valve, pacemaker-lead or 
intra-uterine device were detected, it was often appropriate to advise patients of the need 
for investigation or removal of the implant.  However, since no systematic record is 
kept about who had what implant, contacting patients and doctors was complicated.  It 
became apparent that a better tracking system existed for motor vehicles than for life-
saving medical devices. 
 
An implant tracking system was envisaged; there are several possible approaches 
available.   
• A purpose designed, centralised database maintained by either the public or private 
sector.  Registration may be either obligatory or voluntary.  The database may 
incorporate all devices or be confined to a certain type.  (An example is the 
Norwegian Arthroplasty Register.  Outside the medical device area, registries of 
infectious diseases are widely used.) 
• Hospital based registries (ie at place of implantation). This approach has recently 
become a legislative requirement in the USA for selected implantable devices. 
• ‘Boutique’ registries run by manufacturers.  This can occur in an ad-hoc manner 
where patients return a warranty card as occurs for some cardiac pacemakers. 
• The function may be combined with the collection of administrative data.  This is 
the approach adopted for example in Sweden and Norway. 
 
The Medical Devices study, which is the basis of this thesis, examines the last of these 
options.  The original aims of the project were: 
• To assess the feasibility and potential health and cost benefits of using routinely 
collected administrative data to monitor health outcomes of medical device 
implants. 
• To develop a data collection and record linkage model for the routine determination 
of  a range of intervention outcomes. 
Preface 
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• To assess the cost benefit of the model. 
 
In Australia, several health administrative data-sets are routinely collected.  Almost all 
doctor visits, hospital admissions and deaths are systematically recorded across the 
country.  The existing infrastructure could provide an appropriate means to collect the 
additional data needed for a medical implant register.  It would probably be the most 
cost-effective option and would require minimum system changes.  Importantly, when 
clinical detail is added to national administrative data-sets, a powerful resource is 
created that could be used for health outcomes evaluation.   It is this possibility that will 
be examined in this thesis.
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Introduction 
 
 
To investigate the potential for using administrative data collections for health outcomes 
analysis I decided to conduct a study that would draw its information from all currently 
available electronic national data-sets.  Health service data are collected by the 
Commonwealth government in the Medical Benefits, the Pharmaceutical Benefits, the 
Department of Veterans Affairs, the National Death Index and the National Hospital 
Morbidity collections.  In order to provide the maximum information for analysis, these 
data sets would require linkage at the patient level.  Detailed demographic data is 
collected by the Australian Bureau of Statistics (ABS).  Unfortunately, all personal 
identifiers have been removed from the ABS collection and as a result these data were 
not able to be incorporated.  To test the usefulness of this linked resource for health 
outcomes evaluation, it was necessary to select a medical intervention to examine.  
Implantable medical devices were chosen as a typical, well defined and widely used 
procedure.   
 
In order to provide a comparison with a state-of-the-art, purpose designed health data 
system, it was decided to perform a parallel study in Manitoba, Canada.  Manitoba 
Health collects service data specifically for the purpose of health care evaluation, in 
addition to the needs of administration.  These data are available for approved research 
projects. 
 
During the initial stages of the study, it became apparent that some modifications to the 
original aims would be required. The changes were necessary because of the limited 
availability of Australian data and the poor quality of data that was available.  Taking 
this into account,  I decided to conduct comparative analyses on three different ‘levels’ 
of data quality that were conceivable, if not actually available. 
 
• The currently available Australian data  
• The reasonably high quality data collected in Manitoba  
• A ‘simulated’ data-set that might be available from an integrated health information 
system. This was achieved by using all Australian service data supplemented with 
detail from a private health insurer. 
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Because it involved using and evaluating almost all the relevant administration data 
sets, the implant study provided invaluable insight into the use of nationally collected 
administrative information.  The thesis therefore, has two distinct parts. The first and 
main part, is concerned with the Medical Devices study.  The second part builds from 
my experience in conducting these studies.  It discusses the potential for expansion and 
integration of the existing administrative data system for the purpose of building an 
integrated health record and information system (IHRIS) which would be an essential 
component of a new health care structure based on a quality management  philosophy. 
 
In the first part, Chapter 1 describes the history and state-of-the-art of record linkage in 
Australia and overseas, the need for evaluation and surveillance of new medical 
interventions and the growing industry of health data collection.  Chapter 2 presents an 
overview of the study methodology while Chapter 3 enlarges on the processes involved 
in selecting a study cohort.  Chapters 4-6 describe the Medical Devices study, its 
implementation, results and analysis. Chapter 7 describes the Manitoba study and 
Chapter 8 compares the Manitoba and Australian data collections, pointing out their 
various advantages and limitations.   
 
Chapter 9, which introduces the second part of the thesis, discusses in more detail the 
strengths and limitations of the use of administrative data for research and examines the 
trend towards the introduction of integrated data collections and quality management in 
health care.  The potential for the existing administrative data system to provide a basis 
for an integrated health information system that caters for systemic quality management 
is discussed.  In Chapter 10, recent initiatives supporting the introduction of a quality 
and safety system in Australian health care are reviewed.  The importance of an IHRIS 
to support such a system is discussed.
